ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Tyra Biosciences Inc

Tyra Biosciences Inc (TYRA)

16.49
0.19
( 1.17% )
Updated: 09:51:27

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
16.49
Bid
16.39
Ask
16.63
Volume
5,007
16.34 Day's Range 16.98
10.38 52 Week Range 20.67
Market Cap
Previous Close
16.30
Open
16.34
Last Trade
2
@
16.49
Last Trade Time
09:51:07
Financial Volume
$ 83,190
VWAP
16.6147
Average Volume (3m)
133,990
Shares Outstanding
43,058,747
Dividend Yield
-
PE Ratio
-12.69
Earnings Per Share (EPS)
-1.28
Revenue
-
Net Profit
-55.33M

About Tyra Biosciences Inc

Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Tyra Biosciences Inc is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Tyra Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TYRA. The last closing price for Tyra Biosciences was $16.30. Over the last year, Tyra Biosciences shares have traded in a share price range of $ 10.38 to $ 20.67.

Tyra Biosciences currently has 43,058,747 shares outstanding. The market capitalization of Tyra Biosciences is $701.86 million. Tyra Biosciences has a price to earnings ratio (PE ratio) of -12.69.

TYRA Latest News

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights

Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights PR Newswire CARLSBAD, Calif., March 19, 2024 - Advanced SURF301 Phase 1 oncology study; Initial Phase 1...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 27, 2024 CARLSBAD, Calif., Feb. 27, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a...

Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...

Form 144 - Report of proposed sale of securities

="/Images/box-unchecked.jpg" alt="Checkbox not checked">2500001/27/2020n/a* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.96-5.5014326647617.4517.7615.9619864116.47315226CS
4-3.51-17.552020.47515.830515494817.59843825CS
123.7929.84251968512.720.6711.2413399016.8011527CS
262.6619.233550253113.8320.6710.3810384715.35253981CS
520.583.6455059710915.9120.6710.387987115.38102894CS
156-13.41-44.849498327829.931.364.9310062414.4783139CS
260-13.41-44.849498327829.931.364.9310062414.4783139CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 17.00
(257.89%)
4.27M
XLOXilio Therapeutics Inc
$ 1.7189
(169.00%)
13.51M
BDRXBiodexa Pharmaceuticals PLC
$ 1.5932
(85.47%)
23.88M
PIKKidpik Corporation
$ 5.4185
(65.70%)
6.17M
AKANAkanda Corporation
$ 0.263
(59.49%)
34.93M
GMDAGamida Cell Ltd
$ 0.0437
(-26.18%)
18.73M
UGROUrban Gro Inc
$ 1.3735
(-24.33%)
157.36k
KODKodiak Sciences Inc
$ 5.95
(-20.13%)
214.93k
SHIMShimmick Corporation
$ 5.5401
(-18.53%)
9.89k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.27
(-17.41%)
2.62M
AKANAkanda Corporation
$ 0.263
(59.49%)
34.93M
NKLANikola Corporation
$ 0.953
(4.83%)
25.2M
BDRXBiodexa Pharmaceuticals PLC
$ 1.5932
(85.47%)
23.88M
AKBAAkebia Therapeutics Inc
$ 2.2199
(-0.90%)
21.74M
KTRAKintara Therapeutics Inc
$ 0.1029
(14.97%)
21.35M

Your Recent History

Delayed Upgrade Clock